After its rough beginnings, the agency’s development into a trusted institution was rocky, author Mikkael A. Sekeres says.
New book recounts the FDA’s ‘unholy birth’
After its rough beginnings, the agency’s development into a trusted institution was rocky, author Mikkael A. Sekeres says.